Please try another search
VBI Vaccines Inc., a commercial-stage biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. The company also develops VBI-2601, a protein based immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study to treat solid tumors; VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial; and VBI-2501 that is in preclinical trial to treat Zika virus. In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited; and the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is based in Cambridge, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Steven S. Gillis | 70 | 2016 | Independent Chairperson of the Board |
Jeffery R. Baxter | 62 | 2016 | President, CEO & Director |
Peter A. Patriarca | - | 2018 | Member of Scientific Advisory Board |
Nell Beattie | 35 | 2015 | CFO, Head of Corporate Development & Director |
Eddy A. Bresnitz | - | 2020 | Member of Commercial Advisory Board |
Daniel Shouval | - | 2018 | Member of Scientific Advisory Board |
Damian A. Braga | 67 | 2020 | Chairperson of the Commercial Advisory Board & Independent Director |
Nadia G. Tornieporth | - | 2018 | Member of Scientific & Clinical Advisory Board |
Stefan Thoelen | - | 2018 | Member of Scientific Advisory Board |
Allen Waziri | - | 2018 | Member of Scientific & Clinical Advisory Board |
Stanley A. Plotkin | 90 | - | Member of Scientific Advisory Board |
Michel De Wilde | 74 | 2016 | Independent Director and Chair of Scientific & Clinical Advisory Boards |
Patrick Yung Wen | - | 2018 | Member of Scientific & Clinical Advisory Board |
Pierre Van Damme | - | 2018 | Member of Scientific Advisory Board |
John D. Grabenstein | - | 2020 | Member of Commercial Advisory Board |
Denis R. Burger | 79 | - | Member of Scientific Advisory Board |
Michael D. Decker | - | 2020 | Member of Commercial Advisory Board |
Adam Finn | - | 2018 | Member of Scientific Advisory Board |
Robert Pass | - | 2018 | Member of Scientific Advisory Board |
Joanne Cordeiro | 65 | 2019 | Independent Director |
Michael Lim | - | 2018 | Member of Scientific & Clinical Advisory Board |
Bruce Smith | - | 2018 | Member of Scientific Advisory Board |
Vaughn B. Himes | 62 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review